Transtympanic management of tinnitus

Michael E. Hoffer, Derin Wester, Richard D. Kopke, Peter Weisskopf, Kim Gottshall

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Transtympanic therapy is becoming and important treatment modality for many inner ear disorders. The current therapies aimed at Meniere's disease, sudden sensorineural hearing loss, noise-induced hearing loss, and the tinnitus associated with these disorders and idiopathic tinnitus, however, represents simply an evolutionary step in this treatment modality and must be validated by further scientific study. A number of promising developments including newer more targeted neuroactive medicines, a better understanding of medicine delivery, and the knowledge of the site, origin, and pathophysiology of the symptoms complex will make this therapy more effective. In the future it is possible that many inner ear disorders will be amenable to inner ear medical therapy. Ideally in the future with knowledge of the disease and its etiology the physician will simply pick the established medicine, the established dose, and the established route of administration and achieve a relatively predictable result.

Original languageEnglish (US)
Pages (from-to)353-358
Number of pages6
JournalOtolaryngologic Clinics of North America
Volume36
Issue number2
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Tinnitus
Inner Ear
Therapeutics
Medicine
Noise-Induced Hearing Loss
Sudden Hearing Loss
Meniere Disease
Sensorineural Hearing Loss
Physicians

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Transtympanic management of tinnitus. / Hoffer, Michael E.; Wester, Derin; Kopke, Richard D.; Weisskopf, Peter; Gottshall, Kim.

In: Otolaryngologic Clinics of North America, Vol. 36, No. 2, 01.01.2003, p. 353-358.

Research output: Contribution to journalArticle

Hoffer, Michael E. ; Wester, Derin ; Kopke, Richard D. ; Weisskopf, Peter ; Gottshall, Kim. / Transtympanic management of tinnitus. In: Otolaryngologic Clinics of North America. 2003 ; Vol. 36, No. 2. pp. 353-358.
@article{877a2411596c4d8b9164f2115aa5e599,
title = "Transtympanic management of tinnitus",
abstract = "Transtympanic therapy is becoming and important treatment modality for many inner ear disorders. The current therapies aimed at Meniere's disease, sudden sensorineural hearing loss, noise-induced hearing loss, and the tinnitus associated with these disorders and idiopathic tinnitus, however, represents simply an evolutionary step in this treatment modality and must be validated by further scientific study. A number of promising developments including newer more targeted neuroactive medicines, a better understanding of medicine delivery, and the knowledge of the site, origin, and pathophysiology of the symptoms complex will make this therapy more effective. In the future it is possible that many inner ear disorders will be amenable to inner ear medical therapy. Ideally in the future with knowledge of the disease and its etiology the physician will simply pick the established medicine, the established dose, and the established route of administration and achieve a relatively predictable result.",
author = "Hoffer, {Michael E.} and Derin Wester and Kopke, {Richard D.} and Peter Weisskopf and Kim Gottshall",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/S0030-6665(02)00166-4",
language = "English (US)",
volume = "36",
pages = "353--358",
journal = "Otolaryngologic Clinics of North America",
issn = "0030-6665",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Transtympanic management of tinnitus

AU - Hoffer, Michael E.

AU - Wester, Derin

AU - Kopke, Richard D.

AU - Weisskopf, Peter

AU - Gottshall, Kim

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Transtympanic therapy is becoming and important treatment modality for many inner ear disorders. The current therapies aimed at Meniere's disease, sudden sensorineural hearing loss, noise-induced hearing loss, and the tinnitus associated with these disorders and idiopathic tinnitus, however, represents simply an evolutionary step in this treatment modality and must be validated by further scientific study. A number of promising developments including newer more targeted neuroactive medicines, a better understanding of medicine delivery, and the knowledge of the site, origin, and pathophysiology of the symptoms complex will make this therapy more effective. In the future it is possible that many inner ear disorders will be amenable to inner ear medical therapy. Ideally in the future with knowledge of the disease and its etiology the physician will simply pick the established medicine, the established dose, and the established route of administration and achieve a relatively predictable result.

AB - Transtympanic therapy is becoming and important treatment modality for many inner ear disorders. The current therapies aimed at Meniere's disease, sudden sensorineural hearing loss, noise-induced hearing loss, and the tinnitus associated with these disorders and idiopathic tinnitus, however, represents simply an evolutionary step in this treatment modality and must be validated by further scientific study. A number of promising developments including newer more targeted neuroactive medicines, a better understanding of medicine delivery, and the knowledge of the site, origin, and pathophysiology of the symptoms complex will make this therapy more effective. In the future it is possible that many inner ear disorders will be amenable to inner ear medical therapy. Ideally in the future with knowledge of the disease and its etiology the physician will simply pick the established medicine, the established dose, and the established route of administration and achieve a relatively predictable result.

UR - http://www.scopus.com/inward/record.url?scp=0038068923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038068923&partnerID=8YFLogxK

U2 - 10.1016/S0030-6665(02)00166-4

DO - 10.1016/S0030-6665(02)00166-4

M3 - Article

C2 - 12856303

AN - SCOPUS:0038068923

VL - 36

SP - 353

EP - 358

JO - Otolaryngologic Clinics of North America

JF - Otolaryngologic Clinics of North America

SN - 0030-6665

IS - 2

ER -